ARCHIVES

Mendelsohn Defends ImClone’s Actions And His Role In Development of C225

This article is from The Cancer Letter archive.

Vol. 28 No. 38 | October 18, 2002

Download PDF Visit The Full Archive

Related Articles

Kidney, Bladder Cancer Causes, Treatment, Need More Research, NCI Advisors Find

July 26, 2002

Study Confirms Cancer Risk Increase Due To Combined HRT

January 31, 2003

Lenalidomide Found Effective For Lymphoma In Phase II Trial

December 26, 2008

FDA Advisors Recommend Use of Cytokines GM-CSF, G-CSF In BMT And Chemotherapy

January 4, 1991

NCI Records Clear Flood Of Intervention For Man Accused Of Illegal Payoffs

February 3, 1978

NCI Pulls Back Curtain on “Zone of Uncertainty” — Funding Patterns Released With Little Comment

May 4, 2012